Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dangers of rosuvastatin identified before and after FDA approval.

× No keyword cloud information.

18 in total

Review 1. Drug development: how academia, industry and authorities interact.

Authors: Silvio Garattini; Norberto Perico
Journal: Nat Rev Nephrol Date: 2014-08-05 Impact factor: 28.314

2. Statin treatment rescues FGFR3 skeletal dysplasia phenotypes.

Authors: Akihiro Yamashita; Miho Morioka; Hiromi Kishi; Takeshi Kimura; Yasuhito Yahara; Minoru Okada; Kaori Fujita; Hideaki Sawai; Shiro Ikegawa; Noriyuki Tsumaki
Journal: Nature Date: 2014-09-17 Impact factor: 49.962

Review 3. Rosuvastatin: an independent analysis of risks and benefits.

Authors: Douglas P Zipes; Nathan J Zvaifler; Richard J Glassock; Sid Gilman; Alvaro Muñoz; Victor Gogolak; Leon Gordis; Peter C Dedon; Frederick P Guengerich; Stephen I Wasserman; Joseph L Witztum; Gerald N Wogan
Journal: MedGenMed Date: 2006-06-14

4. More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipients.

Authors: Ida Robertsen; Anders Asberg; Tone Granseth; Nils Tore Vethe; Fatemeh Akhlaghi; Mwlod Ghareeb; Espen Molden; Morten Reier-Nilsen; Hallvard Holdaas; Karsten Midtvedt
Journal: Transplantation Date: 2014-06-27 Impact factor: 4.939

5. Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database.

Authors: Julia Hippisley-Cox; Carol Coupland
Journal: BMJ Date: 2010-05-20

Review 6. Safety of statins: an update.

Authors: Miao Hu; Bernard M Y Cheung; Brian Tomlinson
Journal: Ther Adv Drug Saf Date: 2012-06

7. Oral nanoparticulate atorvastatin calcium is more efficient and safe in comparison to Lipicure in treating hyperlipidemia.

Authors: A K Meena; D Venkat Ratnam; G Chandraiah; D D Ankola; P Rama Rao; M N V Ravi Kumar
Journal: Lipids Date: 2008-01-10 Impact factor: 1.880

Dangers of rosuvastatin identified before and after FDA approval.